Advertisement
Home 2018 November

Monthly Archives: November 2018

Children who are overweight or obese have an increased risk for asthma

Child Overweight, Obesity Linked to Increased Asthma Risk

0
In absence of overweight and obesity, 10 percent of all pediatric asthma cases would be avoided
Even with the rapid rise in popularity of electronic cigarettes

Youth Smoking Decline Mirrors Rise in Vaping Popularity

0
Large rise in youth vaping, decline in past 30-day smoking prevalence accelerated around 2014
The American Lung Association and the American Thoracic Society have established a website to guide implementation of lung cancer screening

Lung Cancer Screening Implementation Guide Developed

0
Implementation guide designed to increase levels of lung cancer screening for heavy smokers
The use of a clinical decision support system in the emergency department can improve outpatient management for patients with acute pulmonary embolism

Clinical Decision Support System Ups Outpatient PE Management

0
Home discharge rate increased at intervention sites; no increase in return visits, adverse outcomes
For patients with prostate cancer

ADT May Up Risk for Heart Failure in Prostate Cancer Patients

0
Heart failure risk higher for androgen deprivation therapy users in propensity score-matched analysis
Obesity is associated with an increased risk for early-onset colorectal cancer among women

Obesity Tied to Increased Risk for Early-Onset CRC in Women

0
Relative risk for early-onset colorectal CA nearly twice as high in obese women as those of normal weight
The abortion rate in the United States fell 24 percent between 2006 and 2015

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

0
Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women
An 18-year-old University of Maryland student has died from an adenovirus-related illness

U of Maryland Student Dies of Adenovirus-Related Illness

0
CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness
The U.S. Food and Drug Administration on Monday approved Gamifant (emapalumab-lzsg) for the treatment of primary hemophagocytic lymphohistiocytosis (HLH) in pediatric (as young as newborn) and adult patients who have refractory

FDA Approves Drug to Treat Rare Immune Disease

0
Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis
The U.S. Food and Drug Administration on Friday announced it has approved Aemcolo (rifamycin)

FDA Approves Drug for Treatment of Travelers’ Diarrhea

0
Aemcolo not indicated for patients with diarrhea complicated by fever and/or bloody stool